Your search returned 9 results.

Sort
Results
1.
Implementation of Basal-Bolus Therapy in Type 2 Diabetes: A Randomized Controlled Trial Comparing Bolus Insulin Delivery Using an Insulin Patch with an Insulin Pen. MedStar authors:
  • Aroda, Vanita R
PMID:
  • 31025878
Year: 2019
Citation:
  • Diabetes Technology & Therapeutics. 21(5):273-285, 2019 May.
Institution:
  • MedStar Health Research Institute
Medline publication type:
  • Journal Article
Form of publication:
  • Journal Article
All authors:
  • Aroda VR, Bailey TS, Bergenstal RM, Brazg RL, Calibra Study Group, Dreon DM, Frias JP, Johnson ML, Klonoff DC, Kruger DF, Levy BL, Naik RG, Peyrot M, Ramtoola S, Rosenstock J, Serusclat P, Shearer DM, Weinstock RS, Zraick V
2.
PIONEER 1: Randomized Clinical Trial of the Efficacy and Safety of Oral Semaglutide Monotherapy in Comparison With Placebo in Patients With Type 2 Diabetes. MedStar authors:
  • Aroda, Vanita R
PMID:
  • 31186300
Year: 2019
Citation:
  • Diabetes Care. 42(9):1724-1732, 2019 09.
Institution:
  • MedStar Health Research Institute
Medline publication type:
  • Journal Article
Form of publication:
  • Journal Article
All authors:
  • Altuntas Y, Aroda VR, Christiansen E, Haluzik M, Hertz CL, Jeppesen OK, Lalic NM, Morales Villegas EC, PIONEER 1 Investigators, Rosenstock J, Terauchi Y
3.
Effect of Dosage Reduction of Hypoglycemic Multidrug Regimens on the Incidences of Acute Glycemic Complications in People With Type 2 Diabetes Who Fast During Ramadan: A Randomized Controlled Trial. MedStar authors:
  • Zaghlol, Raja
PMID:
  • 34305809
Year: 2021
Citation:
  • Frontiers in Endocrinology. 12:613826, 2021.
Institution:
  • MedStar Washington Hospital Center
Department:
  • Internal Medicine Residency
Medline publication type:
  • Journal Article
Form of publication:
  • Journal Article
All authors:
  • Amarin JZ, Beirat AF, Hasan YY, Hassoun Al Najar AM, Qtaishat A, Tierney ME, Zaghlol LY, Zaghlol RY, Zayed AA
4.
Efficacy, Safety, and Tolerability of Oral Semaglutide Versus Placebo Added to Insulin With or Without Metformin in Patients With Type 2 Diabetes: The PIONEER 8 Trial. MedStar authors:
  • Aroda, Vanita R
PMID:
  • 31530667
Year: 2019
Citation:
  • Diabetes Care. 42(12):2262-2271, 2019 12.
Institution:
  • MedStar Health Research Institute
Medline publication type:
  • Journal Article
Form of publication:
  • Journal Article
All authors:
  • Araki E, Aroda VR, Buse JB, Cariou B, Harris SB, Hoff ST, Pedersen KB, PIONEER 8 investigators, Tarp-Johansen MJ, Zinman B
5.
Impact of intensive glycemic control on the incidence of atrial fibrillation and associated cardiovascular outcomes in patients with type 2 diabetes mellitus (from the Action to Control Cardiovascular Risk in Diabetes Study). MedStar authors:
  • Fatemi, Omid
  • Yuriditsky, Eugene
PMID:
  • 25159234
Citation:
  • American Journal of Cardiology. 114(8):1217-22, 2014 Oct 15.
Institution:
  • MedStar Heart & Vascular Institute
Medline publication type:
  • Comparative Study
  • Journal Article
  • Multicenter Study
  • Randomized Controlled Trial
  • Research Support, N.I.H., Extramural
Form of publication:
  • Journal Article
All authors:
  • Basile J, Bigger T, Cushman W, Fatemi O, Goff D, Morgan T, Papademetriou V, Soliman EZ, Thomas A, Tsachris D, Tsioufis C, Yuriditsky E
6.
THE SYNERGY TO ENABLE GLYCEMIC CONTROL FOLLOWING EMERGENCY DEPARTMENT DISCHARGE PROGRAM FOR ADULTS WITH TYPE 2 DIABETES: STEP-DIABETES. MedStar authors:
  • Dubin, Jeffrey S
  • Magee, Michelle
  • Mete, Mihriye
  • Nassar, Carine M
  • White, Keyoana
  • Youssef, Gretchen A
PMID:
  • 26214111
Year: 2015
Citation:
  • Endocrine Practice. 21(11):1227-39, 2015 Nov.
Institution:
  • MedStar Health Research Institute
  • MedStar Washington Hospital Center
  • MedStar Washington Hospital Center
  • MedStar Washington Hospital Center
Department:
  • Emergency Medicine
  • Medicine/Endocrinology
  • MedStar Diabetes Institute
Medline publication type:
  • Journal Article
  • Randomized Controlled Trial
  • Research Support, Non-U.S. Gov't
Form of publication:
  • Journal Article
All authors:
  • Dubin JS, Magee MF, Mete M, Nassar CM, White K, Youssef GA
7.
Efficacy and Safety of Once-Weekly Semaglutide Versus Exenatide ER in Subjects With Type 2 Diabetes (SUSTAIN 3): A 56-Week, Open-Label, Randomized Clinical Trial. MedStar authors:
  • Aroda, Vanita R
PMID:
  • 29246950
Year: 2018
Citation:
  • Diabetes Care. 41(2):258-266, 2018 02.
Institution:
  • MedStar Health Research Institute
Medline publication type:
  • Journal Article
Form of publication:
  • Journal Article
All authors:
  • Ahmann AJ, Annett MP, Aroda VR, Capehorn M, Charpentier G, Dotta F, Henkel E, Holst AG, Lingvay I
8.
Switching to iGlarLixi Versus Continuing Daily or Weekly GLP-1 RA in Type 2 Diabetes Inadequately Controlled by GLP-1 RA and Oral Antihyperglycemic Therapy: The LixiLan-G Randomized Clinical Trial. MedStar authors:
  • Aroda, Vanita R
PMID:
  • 31530665
Year: 2019
Citation:
  • Diabetes Care. 42(11):2108-2116, 2019 11.
Institution:
  • MedStar Health Research Institute
Medline publication type:
  • Journal Article
Form of publication:
  • Journal Article
All authors:
  • Aroda VR, Blonde L, Del Prato S, Frias J, Henry R, Ji C, Niemoeller E, Rosenstock J, Shehadeh N, Souhami E
9.
Optimization of Metformin in the GRADE Cohort: Effect on Glycemia and Body Weight. MedStar authors:
  • Aroda, Vanita R
PMID:
  • 32139384
Year: 2020
Citation:
  • Diabetes Care. 43(5):940-947, 2020 05.
Institution:
  • MedStar Health Research Institute
Medline publication type:
  • Journal Article
Form of publication:
  • Journal Article
All authors:
  • Aroda VR, Butera NM, Camp AW, Cherrington A, Craig J, Fortmann SP, GRADE Research Group, Hollander PA, Krakoff J, Perez M, Phillips LS, Rasouli N, Sivitz WI, Tan MH, Tiktin M, Wexler DJ, Younes N
Pages

Powered by Koha